Related Experiment Video
Updated: May 2, 2026
10:36
A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
Published on: January 9, 2018
6.8K
The IL-6 feed-forward loop: a driver of tumorigenesis
Qing Chang1, Laura Daly1, Jacqueline Bromberg2
1Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA.
Seminars in Immunology
|March 12, 2014
Summary
Interleukin-6 (IL-6) signaling drives tumor growth and spread. While blocking IL-6 works in early studies, its clinical effectiveness varies, necessitating biomarkers for patient selection in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- Interleukin-6 (IL-6) is a cytokine implicated in various stages of cancer development, including tumorigenesis and metastasis.
- The IL-6 signaling pathway exerts both tumor-intrinsic and tumor-extrinsic effects that promote cancer progression.
Purpose of the Study:
- To review current evidence on the roles of IL-6 signaling in cancer.
- To evaluate the efficacy of IL-6 pathway blockade in preclinical models versus clinical settings.
- To highlight the need for predictive biomarkers for anti-IL-6 therapies.
Main Methods:
- Comprehensive literature review of studies investigating IL-6 signaling in cancer.
- Analysis of preclinical data on tumor growth and metastasis inhibition by IL-6 blockade.
- Assessment of clinical trial outcomes for anti-IL-6 therapies.
Main Results:
- Preclinical models show significant reduction in tumor growth and metastasis upon IL-6 pathway blockade.
- Clinical success of anti-IL-6 therapies is less consistent, indicating a gap between preclinical promise and patient outcomes.
- Tumor-intrinsic and extrinsic functions of IL-6 contribute to its pro-tumorigenic effects.
Conclusions:
- IL-6 signaling is a critical driver of tumorigenesis and metastasis.
- While IL-6 blockade is effective in preclinical settings, its clinical application requires further refinement.
- Identifying predictive biomarkers for patient response is crucial for optimizing anti-IL-6 cancer therapy.
Related Concept Videos
01:07Cell Signaling Feedback Loops
5.8K
Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
5.8K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
03:03mTOR Signaling and Cancer Progression
1.5K
1.5K
01:19Interactions Between Signaling Pathways
4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K